American Regent is recalling all lots of Ketorolac Tromethamine Injection, USP, 15 mg/mL, 1mL single dose vial, with the NDC number 0517-0601-25. The product is used to treat moderate to severe ...

Ketorolac tromethamine 15mg/mL, 30mg/mL; for IM or IV inj; contains alcohol. Do not exceed 5 days' combined (inj + tabs) therapy or recommended dose (may use as-needed opioids for breakthrough ...

October 22, 2009 — American Regent has issued a voluntary recall of all lots of ketorolac tromethamine injection, 30 mg/mL, the US Food and Drug Administration (FDA) announced yesterday.

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi USA is voluntarily recalling a single lot of Ketorolac Tromethamine Injection, USP, 30 mg/mL, 1 mL fill in a 2 mL amber vial to the user level ...

Fresenius Kabi announced the availability of Ketorolac Tromethamine Injection 15mg/mL in Simplist prefilled syringes. Fresenius Kabi announced the availability of Ketorolac Tromethamine Injection ...

Hikma Pharmaceuticals USA Inc. Extends Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP 30mg/mL, 1mL Fill/2mL Vials Due to the Potential Presence of Small Particulates March 3 ...

Fresenius pulled one lot of Ketorolac Tromethamine Injection after particulates turned up in sample vials on reserve. The recall covers a 30-mg dose of the anti-inflammatory drug, which was ...

The release reads: FRESENIUS KABI ISSUES VOLUNTARY NATIONWIDE RECALL OF 13 LOTS OF KETOROLAC TROMETHAMINE INJECTION, USP DUE TO THE PRESENCE OF PARTICULATE MATTER IN RESERVE SAMPLES Fresenius Kabi ...